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ABSTRACT
Background: Cardiovascular disease (CVD) represents a leading cause
of mortality worldwide, especially in the elderly. Lowering the number
of CVD deaths requires preventive strategies targeted on the elderly.
Objective: The objective was to generate evidence on the association
between WHO dietary recommendations and mortality from CVD,
coronary artery disease (CAD), and stroke in the elderly aged $60 y.
Design: We analyzed data from 10 prospective cohort studies from
Europe and the United States comprising a total sample of 281,874
men and women free from chronic diseases at baseline. Components
of the Healthy Diet Indicator (HDI) included saturated fatty acids,
polyunsaturated fatty acids, mono- and disaccharides, protein, choles-
terol, dietary fiber, and fruit and vegetables. Cohort-specific HRs ad-
justed for sex, education, smoking, physical activity, and energy and
alcohol intakes were pooled by using a random-effects model.
Results: During 3,322,768 person-years of follow-up, 12,492 people
died of CVD. An increase of 10 HDI points (complete adherence to an
additional WHO guideline) was, on average, not associated with CVD
mortality (HR: 0.94; 95% CI: 0.86, 1.03), CAD mortality (HR: 0.99;
95% CI: 0.85, 1.14), or stroke mortality (HR: 0.95; 95% CI: 0.88, 1.03).
However, after stratification of the data by geographic region, adherence
to the HDI was associated with reduced CVD mortality in the southern
European cohorts (HR: 0.87; 95% CI: 0.79, 0.96; I2 = 0%) and in the
US cohort (HR: 0.85; 95% CI: 0.83, 0.87; I2 = not applicable).
Conclusion: Overall, greater adherence to the WHO dietary guide-
lines was not significantly associated with CVD mortality, but the
results varied across regions. Clear inverse associations were observed
in elderly populations in southern Europe and the United States.
Am J Clin Nutr 2015;102:745–56.
Keywords: aging, CHANCES, cardiovascular disease, cohort,
meta-analysis
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INTRODUCTION
The prevention of cardiovascular disease (CVD)24 later in life
is of increasing public health interest, because the number of
elderly people is growing constantly and the occurrence of CVD
increases with advancing age (1). Evidence on potential risk
factors for disease development and mortality is limited and in-
conclusive for older adults. Therefore, consortia such as the Con-
sortium on Health and Ageing: Network of Cohorts in Europe and
the United States (CHANCES) have been formed to examine risk
factors in an exclusively elderly population (aged $60 y) to pro-
vide evidence for the prevention of premature death.
Diet is an important modifiable risk factor for CVD incidence
(2), even in the elderly (1, 3). To maximize the reduction of CVD
through diet, evidence-based, country-specific dietary guidelines
were formulated and operationalized into healthy diet scores.
Examples for such dietary pattern indexes are the Healthy Eating
Index of the United States (4) and the Dutch Healthy Eating Index
(5), which are useful for investigating country-specific associa-
tions between dietary quality and CVD. Thus far, evidence from
multiple countries on the association between a healthy diet,
defined as the adherence to dietary recommendations, and CVD
mortality was not comparable enough to perform a meta-analysis
(6). However, such data are important for drawing a convincing
conclusion on the benefits of a healthy diet on CVD.
Deriving comparable data on dietary quality across cohorts
requires a globally applicable dietary quality score (7, 8). The
Healthy Diet Indicator [HDI (9)], based on WHO’s 2003 (10)
nutrient intake goals to prevent chronic diseases worldwide,
represents a globally applicable diet quality index that has been
shown to be associated with all-cause mortality (9, 11, 12). All
WHO recommendations were set after a proper review of most
recent literature on diet and health (10). The indicator includes
recommendations on the intake of dietary fatty acids (which af-
fect plasma lipids and lipoproteins), total carbohydrates and free
sugars (which mainly affect body fatness), cholesterol (as
a marker for animal products), protein (which potentially in-
fluences blood lipid concentrations, blood pressure, and body
weight), sodium (which affects blood pressure), fruit and vege-
tables (which have anti-inflammatory and antioxidant effects),
and dietary fiber (which affect insulin sensitivity, blood pressure,
lipids, and inflammation) (10, 13).
The aim of this meta-analysis was to add to the current
knowledge regarding the potential benefits of adhering to
a healthy diet (HDI) by preventing CVDmortality in the elderly.
Furthermore, we evaluated whether this association would
differ by age, sex, and geographic location. The current analy-
sis complements a previous study that we conducted within
CHANCES on the association between a healthy diet and lon-
gevity using all-cause mortality as the outcome (11). In the
current study, we focused on the benefits of a healthy diet re-
garding cause-specific CVD mortality. Most importantly, the
number of included cohorts allowed the additional analysis of
coronary artery disease (CAD) and stroke mortality, which has
seldom been analyzed in previous studies.
METHODS
We conducted an individual participant–based meta-analysis
within CHANCES (www.chancesfp7.eu). Its aim is to combine
and integrate prospective cohort studies to produce, improve,
and clarify the evidence on the distribution and risks factors for
chronic diseases in the elderly and their socioeconomic impli-
cations. Elderly were defined by the CHANCES consortium as
being aged $60 y. The cohorts of CHANCES were chosen
because they undertook the efforts to harmonize all variables
needed for this project according to predefined rules. The har-
monization rules were discussed among the CHANCES partners
until a consensus was reached.
We included participants aged $60 y (according to the
definition of elderly by CHANCES) from the European Pro-
spective Investigation into Cancer and Nutrition Elderly study
(EPIC-Elderly) (14) [Spain (ES), the Netherlands (NL), Greece
(GR), and the northern part of EPIC-Elderly Sweden (SE)];
the Health, Alcohol and Psychosocial factors in Eastern Eu-
ropean countries (HAPIEE) (15) [Czech Republic (CZ),
Russia (RU), and Poland (PL)]; the NIH-AARP Diet and
Health Study in the United States, which included the fol-
lowing US regions: California, Louisiana, Florida, Atlanta,
North Carolina, New Jersey, Pennsylvania, and Detroit (16);
the Rotterdam Study (17) [Netherlands (NL)]; and the Survey
in Europe on Nutrition and the Elderly; a Concerted Action
(SENECA) (18) [multicenter European Study (European Un-
ion; EU)]. Before conducting the analysis, we excluded par-
ticipants with incomplete follow-up information relevant to
the analysis. We also excluded participants with missing in-
formation on age, chronic diseases (CVD, diabetes, and can-
cer) at baseline, missing or implausible information on BMI
(in kg/m2; if BMI .60 or ,10), and an unknown cause of
death. A total number of 281,874 (74% of the original source
population, see Supplemental Table 1) remained for further
analysis. The Rotterdam Study and NIH-AARP showed di-
etary intake outliers, which we removed by Box-Cox trans-
formation (i.e., participants beyond twice the IQR above the
75th or below the 25th percentile of sex-specific Box-Cox
transformed energy intake were excluded).
The main characteristics of the cohorts were described pre-
viously (14–16, 18–22) and are summarized in Supplemental
Table 1. In all of the cohorts, the procedures followed were in
accordance with the ethical standards of the responsible in-
stitutional or regional committee on human experimentation,
and all participants gave written informed consent.
CVD mortality
CVD causes of death were defined by the following In-
ternational Classification of Diseases (ICD) codes: ICD8 (390–
458), ICD 9 (390–459), and ICD10 (100–199). CAD was defined
2Supplemental Tables 1 and 2 are available from the “Supplemental data”
link in the online posting of the article and from the same link in the online
table of contents at http://ajcn.nutrition.org.
24Abbreviations used: CAD, coronary artery disease; CHANCES, Consortium
on Health and Ageing: Network of Cohorts in Europe and the United States;
CVD, cardiovascular disease; CZ, Czech Republic; EPIC-Elderly, European
Prospective Investigation into Cancer and Nutrition elderly study; ES, Spain;
EU, European Union; FFQ, food-frequency questionnaire; GR, Greece; HA-
PIEE, Health, Alcohol and Psychosocial factors in Eastern European countries;
HDI, Healthy Diet Indicator; ICD, International Classification of Diseases; NL,
Netherlands; PL, Poland; RU, Russia; SE, Sweden; SENECA, Survey in Eu-
rope on Nutrition and the Elderly; a Concerted Action.
*To whom correspondence should be addressed: E-mail: edith.feskens@wur.nl.
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by the following codes: ICD8 (410–414), ICD 9 (410–414), and
ICD10 (120–125); and stroke by the following codes: ICD8
(430–438), ICD 9 (430–438), and ICD10 (160–169). Missing
values for specific causes of death were ,8% across cohorts.
Participants with unknown cause of death were excluded from
the analysis (n = 39,259; 10%). Start of follow-up was defined as
age at baseline, and end of follow-up was defined as age of the
participant at last linkage with the death registry (Supplemental
Table 1).
Dietary assessment
Different dietary-assessment methods were applied in each
cohort. Most cohorts applied a validated food-frequency ques-
tionnaire (FFQ) (14–16, 18, 20–22). SENECA and EPIC-Elderly
ES used a validated dietary-history method (23). HAPIEE applied
the Whitehall II Study FFQ (15). The dietary-assessment methods
applied in each of the cohorts were considered to be valid and
reproducible. More information on the validity and reproducibility
can be found elsewhere (23–32). The total number of either FFQ
or dietary-history items, reference periods, and interview or self-
reported assessments differed across cohorts. Foods were trans-
lated into nutrients by using country-specific food-composition
tables. The cohort-specific definition for the food group “fruit and
vegetables” is given in Supplemental Table 1.
HDI
Huijbregts et al. (9) introduced the HDI for assessing the level
of dietary quality within a population according to the WHO
dietary guidelines, as published in 1990 (33). We substituted the
WHO guidelines published in 1990 with the updated 2003 WHO
guidelines on diet and nutrition to prevent chronic disease (10). In
addition, the initial dichotomous scoring system (9) was replaced
by a continuous scoring system, because this deals more effi-
ciently with between-person variation and can better reveal diet-
disease associations (6, 34). WHO components (as updated in
2003) and scoring standards are shown in Table 1. All cohorts
had information on 9 nutrients and 1 food group out of the 14
WHO goals. Five of the 10 cohorts (3 cohorts of the HAPIEE
study plus the NIH-AARP study and the Rotterdam Study) had
information on all 10 codable dietary intake goals. To increase
comparability across cohorts and with previous publications (9),
we focused on the following 7 HDI components, which were
available in all cohorts: percentage of energy intake from SFAs,
PUFAs, mono- and disaccharides, and protein; cholesterol (mg/d),
fruit and vegetables combined (g/d); and either total dietary
fiber or nonstarch polysaccharides (g/d). The intake of n23
PUFAs, n26 PUFAs, trans fatty acids, and sodium were not
included in the score. Furthermore, as suggested before (9), we
excluded total fat and total carbohydrates from the HDI score
calculation to avoid duplicating weights for these 2 components.
We excluded MUFAs, because the WHO guideline does not
account for the intake of MUFAs. Dietary fiber was used for the
HDI calculation in all cohorts except HAPIEE, for which only
nonstarch polysaccharide was available. Free sugars were not
available in all cohorts and were replaced by mono- and di-
saccharides. According to the WHO guidelines, all macronu-
trients were expressed as a percentage of energy intake. For the
calculation of nutrient densities, we excluded energy provided
by ethanol, as performed earlier (9).
TABLE 1
Operationalization of the HDI based on WHO’s 2003 guidelines: CHANCES1
HDI component Standard for minimum score of 0 points
Standard for continuous scoring
of 0 to 10 points
Standard for maximum score
of 10 points2
Moderation components
SFAs, % of energy3 .15 10–154 0–10
Mono- and disaccharides, % of energy3,5 .30 10–304 0–10
Cholesterol, mg/d .400 300–4004 0–300
Moderation range components
PUFAs, % of energy3 .10 0–66 6–10
Protein, % of energy3 .20 0–106 or 15–204 10–15
Adequacy components
Total dietary fiber, g/d7 0 0–256 .25
Fruit and vegetables, g/d 0 0–4006 .400
1WHO guidelines not scored because of overlap with included components: total fat, MUFAs, and total carbohydrates. WHO guidelines that were not
scored because of a lack of information: n23 PUFAs, n26 PUFAs, trans fatty acids, and sodium. CHANCES, Consortium on Health and Ageing: Network of
Cohorts in Europe and the United States; HDI, Healthy Diet Indicator.
2Standard in accordance with WHO guidelines.
3Excluding energy from alcohol.
4The upper cutoff value at which a participant would score 0 points was based on the 85th percentile of the population’s intake distribution. Calculation of
points for dietary intake between the upper limit and the standard intake for maximum number of points: 10 2 (intake 2 recommendation upper limit) 3
(10 O standard upper limit 2 recommendation upper limit).
5Free sugars were replaced by mono- and disaccharides.
6Calculation of points for dietary intake between the lower limit and the standard intake for maximum number of points: (intake O standard lower
limit) 3 10.
7The joint WHO/FAO guidelines of 2003 do not indicate clear fiber cutoff values. Fulfillment of the fruit and vegetable recommendation and consumption
of whole grains should sum up to 20 g nonstarch polysaccharides, which equals w25 g dietary fiber. Fiber was not available for Health, Alcohol and
Psychosocial factors in Eastern European countries (HAPIEE). Therefore, we applied nonstarch polysaccharides instead for that cohort with a standard
maximum score of 20.
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The HDI includes 3 different categories of guidelines
(“moderation,” “moderation range,” and “adequacy”) with ac-
companying scoring systems. The maximum score of 10 points
was allocated if the intake was in accordance with the WHO
guideline. For the moderation category (SFAs, mono- and di-
saccharides, and cholesterol), participants with a higher intake
than recommended received proportionally fewer points, with
a minimum of 0 points at the upper limit. The upper limit was
defined as the 85th percentile of the combined cohort-specific
population distribution (35). The “moderation range” compo-
nents (PUFAs, 6–10% of energy; protein, 10–15% of energy)
were scored with a maximum of 10 points if intake was within
the recommended range. A score of zero corresponded to an
intake of zero at the lower limit or the .85th percentile at the
upper end. For PUFAs, 85% of our participants met the WHO
guidelines, i.e., the upper limit was included in the recom-
mended range. Therefore, all participants with a PUFA intake
above the recommended range received 0 points. For the
“adequacy” components (fiber, .25 g/d; fruit and vegetables,
.400 g/d), participants received 10 points if they met the guide-
lines, whereas participants with lower intakes were allocated
proportionately fewer points, with 0 g/d as the minimum.
After all individual scores were summed, a participant would
receive the maximum HDI score of 70 points if all of the
guidelines were met and the minimum HDI score of 0 if none of
the guidelines was met (36).
Covariates
Sex, education, alcohol consumption, smoking status, and en-
ergy intake were assessed by study-specific questionnaires and
were available for all cohorts. Data on measured weight and height
were available for EPIC-Elderly, the Rotterdam Study, and
SENECA; self-reported datawere provided by the NIH-AARP and
HAPIEE studies. In the Rotterdam Study, no baseline measure for
physical activity was available. For participants of the Rotterdam
Study, we used physical activity assessed 7 y after baseline as
a proxy measure for physical activity at baseline. Physical activity,
for participants dying within the first 7 y after baseline, was coded
as missing. Data on physical activity in EPIC-Elderly SE was not
available for this study and was therefore not included as
a covariate for any analysis performed in EPIC-Elderly SE. The
following variables were available in some but not all cohorts and,
therefore, were additionally included in the multivariate model but
not considered for the pooled analysis: use of lipid-lowering drugs
was available in EPIC-Elderly GR and the Rotterdam Study,
history of hypertension (self-reported or documented) was known
for EPIC-Elderly (ES, NL, GR, and SE), the Rotterdam Study, and
SENECA. Information on multivitamin use was available for the
Rotterdam Study only. Potential confounders were selected on the
basis of prior knowledge regarding their association with dietary
patterns and CVD risk.
Statistical analysis
This meta-analysis of individual participant data followed a
2-step approach by analyzing each of the 10 cohorts individually,
first by using the same analysis script and thereafter by con-
ducting meta-analyses of the obtained effect estimates.
All analyses were performed by using the same analysis script.
Cox proportional hazard models, with age applied as the un-
derlying time variable, were used to assess the association be-
tween the HDI score (per 10-point increment, equivalent to the
adherence of an additional WHO recommendation and in
agreement with the cohort-specific IQRs) and subsequent CVD,
CAD, and stroke mortality. SENECAwas analyzed as one cohort
because of the low number of cases per participating country. The
cohort-specific HRs were summarized by random-effects meta-
analysis to take differences in sample size and the possibility
of statistical heterogeneity among the studies into account.
Between-study heterogeneity was judged by I2 statistics. I2 statistics
should be interpreted as the level of inconsistency across HR
estimates instead of the real variation across the underlying true
effects (37). To verify that our result was not solely driven by
NIH-AARP, we conducted a random-effects meta-analysis and
additionally stratified by region.
The final HR was adjusted for sex, education (primary or less,
more than primary but less than college or university, or college
or university), alcohol consumption [low (0 g/d), medium (men
.0–40 g/d and women .0–20 g/d), and high (men .40 g/d and
women .20 g/d)], smoking status (never, former, or current),
energy intake (kcal/d), and vigorous physical activity (yes or
no). Participants with missing data for the confounding variables
were included by a separate category for these variables. BMI
was initially not included in the main model because of its po-
tential influence on the association as an intermediate factor.
However, to assess whether BMI had any influence on the
pooled results, additional adjustment was performed in a sensi-
tivity analysis. We included “center” for EPIC-Elderly multi-
center cohorts (ES and NL) and “region” for SENECA in all
models to adjust for potential differences in baseline hazards
across centers or regions.
In an additional analysis, we ran models for the Rotterdam
Study, EPIC-Elderly GR, and NIH-AARP, for which we had
additional data available on hypertension at baseline, use of
statins, and multivitamins. Inclusion of those variables did not
change the hazard estimates to any material extent. To examine
the importance of excluded HDI components (n23 and n26
PUFAs as separate components, trans fatty acids, and sodium) to
the association between WHO guidelines and CVD mortality,
we additionally investigated the complete HDI score based on
10 WHO components in HAPIEE, NIH-AARP, and the Rotter-
dam Study.
Potential effect modification by age, sex, BMI, smoking, ed-
ucation, and alcohol consumption was investigated in each cohort
by including an interaction term between these variables and the
HDI score. Furthermore, we stratified the results on a healthy diet
and CVD mortality for potential effect modifiers to address het-
erogeneity. To examine possible sources of heterogeneity, we
compared the pooled HR estimates and I2 values for CVD mor-
tality with the CVD mortality estimates of stratified analyses.
Stratified analyses by potential effect modifiers were limited to
CVD mortality, because the numbers of CAD and stroke cases
were too small for cohort-specific subgroup analyses. For the
analysis stratified by geographic region, we categorized SENECA
cohorts into northern [Belgium, Denmark, France (Hagenau),
Netherlands, and Switzerland (Burgdorf)] and southern [France
(Romans), Greece, Italy, Portugal, Spain, and Switzerland (Yverdon
and Bellinzona)] European countries. EPIC-elderly ES and GR
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were classified as southern Europe, and EPIC-Elderly NL and
SE were classified as northern Europe.
In a sensitivity analysis, we studied the influence of possible
dietary changes after disease occurrence on HRs. We excluded
participants who died within the first 2 y of follow-up, as
performed earlier (38). Finally, to investigate the importance of
specific HDI components, we excluded one HDI component at
a time and included them as a covariable instead (39).
Cohort-specific data were analyzed by using SAS version
9.2. For the random-effects meta-analysis, the metafor package
in R (version 2.15.0) was used. A P value ,0.05 was con-
sidered to be statistically significant.
RESULTS
Table 2 shows the baseline characteristics of the 281,874
included CHANCES participants. A total of 3,322,768 person-
years were accumulated across studies. During that time,
12,492, 6004, and 2401 people died of CVD, CAD, and
stroke, respectively. The proportion of deaths due to CVD,
CAD, and stroke was highest in SENECA (all participants
aged $70 y), followed by the Rotterdam Study (longest follow-
up). At baseline, the mean age ranged from 60 y in EPIC-
Elderly SE to 73 y in SENECA (Table 2). The mean BMI
ranged from 26 in the 2 northern European EPIC-Elderly
cohorts (NL and SE) and the Rotterdam Study to 29 in EPIC-
Elderly ES and GR. The median HDI scores (maximum: 70
points) ranged from 42 (IQR: 37–47) in HAPIEE (RUS and
PL) to 54 (IQR: 49–59) in EPIC-elderly GR.
Tables 3 and 4 show the overall HDI scores and their
components for the lowest and highest HDI quartile per co-
hort. For most single HDI items, the difference in intake be-
tween the lowest and highest quartiles were as expected.
However, across cohorts, differences in associations with the
HDI score were observed for PUFAs and mono- and di-
saccharides. A positive association between HDI and mean
PUFA intake—in a comparison of the highest with the lowest
HDI quartile—was observed in EPIC-Elderly (NL and SE),
the Rotterdam Study, and HAPIEE (PL); an inverse associa-
tion in EPIC-Elderly (ES and GR), HAPIEE (CZ), NIH-
AARP, and SENECA; and no association in HAPIEE (RUS).
In addition, we observed a positive association between HDI
and mean mono- and disaccharide intake in EPIC-Elderly
(NL), the Rotterdam Study, HAPIEE (CZ), and NIH-AARP;
an inverse association was found in EPIC-Elderly (ES, GR,
and SE) and SENECA, and no association was found in
HAPIEE (RUS and PL).
Figure 1 shows the cohort-specific and pooled HRs for
CVD, CAD, and stroke mortality per 10-point increase in
the HDI (representing the adherence to an additional WHO
guideline), after adjustment for sex, education, smoking status,
energy intake, alcohol consumption, and physical activity. For
CVD mortality, HRs per 10-point increases ranged from 0.84
for EPIC-Elderly GR to 1.21 for EPIC-Elderly SE. In the
pooled analysis, on average, a nonsignificant reduction of 6%
(HR: 0.94; 95% CI: 0.86, 1.03) in CVD mortality was ob-
served, per 10-point increases in HDI. Heterogeneity was high
(I2 = 68%). Additional adjustment for BMI did not influence
the pooled HR estimate for CAD (HR: 0.94; 95% CI: 0.86, TA
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1.03), CVD (HR: 0.95; 95% CI: 0.83, 1.09), and stroke (HR:
0.94; 95% CI: 0.89, 1.00).
For CAD mortality, HRs ranged from 0.75 for EPIC-Elderly
GR and HAPIEE (RUS) to 1.40 for EPIC-Elderly NL; no
association was observed across cohorts (HR: 0.99; 95% CI:
0.85, 1.14; I2 = 67%). HR estimates for stroke mortality
ranged from 0.74 for HAPIEE (CZ) to 1.23 for the Rotterdam
Study. Overall average risk reduction for stroke mortality
amounted to 5% (HR: 0.95; 95% CI: 0.88, 1.03; I2 = 7%).
The significance levels for interaction derived in each cohort
separately did not suggest effect modification. However, strat-
ified analysis showed reduced levels of heterogeneity after
stratification in most cases. For CVD deaths, the pooled HRs
were similar for men and women (I2 = 56% for men and 63% for
women) (Table 5). Participants aged $70 y showed a slightly
stronger association (HR: 0.91) compared with the overall es-
timate (HR: 0.94). A significant inverse association (HR: 0.89;
95% CI: 0.83, 0.96; I2 = 24%) between HDI and CVD mortality
was observed for participants with a BMI $27 but not for
participants with a BMI ,27. Significant inverse associations
with low heterogeneity were also observed in former smokers,
medium-level-educated subjects, and no or high alcohol users.
The inclusion of additionalWHOcomponents in theHDI score,
in the 5 cohorts with available data, showed estimates similar to the
results derived in themain analysis.We observed a narrower CI but
a greater level of heterogeneity (HR: 0.93; 95%CI: 0.80, 1.07; I2 =
81%) in contrast with the overall result derived in these 5 cohorts
(HR: 0.94; 95% CI: 0.81, 1.09; I2 = 75%).
Stratification by geographic region showed a significant
inverse association between the HDI and CVD mortality in the
US (HR: 0.85; 95%CI: 0.83, 0.87) and southern European (HR:
0.87; 95% CI: 0.79, 0.96; I2 = 0%) cohorts but not in the
central eastern European (HR: 0.96; 95% CI: 0.70, 1.31; I2 =
67%) and northern European (HR: 1.02; 95% CI: 0.85, 1.24;
I2 = 63%) cohorts (Table 5). HDI showed a strong inverse as-
sociation with CAD and stroke mortality in the United States
and slightly stronger, albeit nonsignificant inverse, associa-
tions in the southern European cohorts compared with the
overall pooled results for CAD and stroke. The northern Eu-
ropean and central eastern cohorts showed no significant as-
sociations between HDI and any of the mortality outcomes.
Exclusion of the first 2 y of follow-up showed similar results
compared with the main analysis.
Finally, further sensitivity analyses were carried out to in-
vestigate the importance of the single HDI components by
excluding themone at a time from theHDI and including them as
a covariable instead (Supplemental Table 2). The analysis
showed robust pooled HR estimates for CVD and stroke mor-
tality, ranging from 0.93 for CVD and 0.94 for stroke (ex-
cluding SFAs, PUFAs, or mono- and disaccharides) mortality to
0.96 for CVD (excluding fruit and vegetables) and 0.97 for
stroke mortality (excluding PUFAs and fruit and vegetables).
HR estimates for CAD were less robust and mostly influenced
by PUFAs (HR: 0.92) and cholesterol (HR: 0.91)
DISCUSSION
Our study included 10 cohorts from Europe and the United
States and comprised a total sample of 281,874 elderly par-
ticipants, free of disease at baseline, with 12,492 CVD, 6004TA
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CAD, and 2401 stroke deaths. The overall results for the asso-
ciation between the HDI guidelines and CVD, CAD, and stroke
mortality showed, on average, no significant associations. HRs
were similar in men and women, but varied across the BMI,
smoking, alcohol use, and education categories. Geographic
region appeared to be of main importance. Based on our data, the
inverse association of HDI and CVD mortality appears con-
vincing for the southern European countries and the United
States, whereas the absence of an association in northern and
central Eastern Europe was unexpected.
Previously, Huijbregts et al. (9) examined adherence to the
1990 WHO recommendations in men aged 50–70 y in relation
to 20-y mortality. Participants from Finland, Italy, and the
Netherlands—whose diet was in accordance with the WHO
guidelines—had a significant 18% lower risk of dying from
CVD compared with the group with the lowest adherence. In
line with our findings for northern Europe, more recent studies
showed no significant association between the HDI and CVD
mortality in elderly men from Sweden (40) and the United
Kingdom (41). The HDI includes subscores on SFAs, PUFAs,
mono- and disaccharides, protein, cholesterol, fiber, and fruit
and vegetables. As such, it was inversely associated with all-
cause mortality in our CHANCES cohorts (HR: 0.90; 95% CI:
0.87, 0.93), with no evidence for regional variation regarding
the direction of association (11). In our study, differences in
food patterns across cohorts may have caused opposed asso-
ciations between PUFAs and the HDI, which might partly
explain the heterogeneous results in HR estimates between
CVD mortality and all-cause mortality (11). For example,
southern European diets (ES and GR) are characterized by
a high consumption of plant foods, such as oils, whereas
northern European diets (NL and SE) include a higher con-
sumption of margarine, dairy products, sugar, potato, and
processed meat (42). The composition of PUFAs within a di-
etary pattern may be more important in the context of CVD
mortality than for all-cause mortality regarding the reduction
in risk of premature death. However, the explanation for the
observed difference in results for the association of the HDI
FIGURE 1 Cohort-specific and pooled HRs of CVD, CAD, and stroke mortality in relation to a 10-point increase in the Healthy Diet Indicator, adjusted
for sex, education, smoking status, energy intake, alcohol consumption, and physical activity in CHANCES, 1988–2011. The bars represent 95% CIs. I2 values
are expressed as a percentage of total variability due to heterogeneity. All data were obtained from the CHANCES consortium (www.chancesfp7.eu).
Participants were from SENECA (18), the Rotterdam Study (17), EPIC-Elderly (14), NIH-AARP (16), and HAPIEE (15). CAD, coronary artery disease;
CHANCES, Consortium on Health and Ageing: Network of Cohorts in Europe and the United States; CVD, cardiovascular disease; CZ, Czech Republic;
EPIC-Elderly, European Prospective Investigation into Cancer and Nutrition elderly study; ES, Spain; EU, European Union; HAPIEE, Health, Alcohol and
Psychosocial factors in Eastern European countries; GR, Greece; NL, Netherlands; PL, Poland; RUS, Russia; SE, Sweden; SENECA, Survey in Europe on
Nutrition and the Elderly; a Concerted Action.
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and CVD with all-cause mortality and the reported regional
differences of the current analysis remain speculative.
The northern European cohorts showed no association be-
tween WHO guidelines and CVD. One important food in the
northern diet is margarine, which in the past was a potential
source of trans fatty acids (43, 44) and was shown to increase
the risk of CVD (43–45). The underlying food pattern of central
eastern European countries might also have caused absent as-
sociations between the HDI and CVD mortality in the current
study (20). One exception was HAPIEE RUS, which showed
a significant inverse association for CVD mortality. NIH-AARP
showed an HDI profile similar to that observed in southern
TABLE 5
HRs and 95% CIs stratified by potential effect modifiers and cohort-specific characteristics for the association of a
10-point increment in the Healthy Diet Indicator and mortality due to CVD, CAD, and stroke: CHANCES1
Outcome variable and strata CVD deaths/participants, n HR and 95% CI2 I2, %
Stratified analysis by potential effect modifiers of CVD only
Sex
Men 7938/152,804 0.93 (0.84, 1.04) 56
Women 4554/127,976 0.93 (0.82, 1.05) 63
Age group
60–70 y 10,914/265,707 0.94 (0.84, 1.04) 72
.70 y 1576/1628 0.91 (0.83, 1.00) 19
BMI
,27 kg/m2 6730/166,661 0.98 (0.87, 1.11) 66
$27 kg/m2 5762/115,655 0.89 (0.83, 0.96) 24
Smoking
Never 3528/109,543 0.95 (0.84, 1.08) 64
Former 5711/130,518 0.84 (0.81, 0.87) 0
Current 2709/32,371 0.93 (0.84, 1.04) 32
Education
Primary or less 1339/19,002 0.91 (0.79, 1.05) 68
More than primary 3726/76,891 0.88 (0.84, 0.92) 0
College or university 7035/178,911 1.07 (0.78, 1.48) 55
Geographic region3
CVD
US 10,498/249,568 0.85 (0.83, 0.87) NA
EU 1994/32,306 0.96 (0.87, 1.06) 55
CEE 281/7373 0.96 (0.70, 1.31) 67
Southern Europe 790/12,640 0.87 (0.79, 0.96) 0
Northern Europe 923/12,293 1.02 (0.85, 1.24) 63
CAD
US 5366/249,568 0.83 (0.80, 0.86) NA
EU 638/32,306 1.00 (0.85, 1.18) 52
CEE 149/7373 1.15 (0.64, 2.06) 79
Southern Europe 262/12,640 0.88 (0.72, 1.08) 44
Northern Europe 227/12,293 1.16 (0.94, 1.42) 0
Stroke
US 6811/249,568 0.93 (0.87, 0.99) NA
EU 590/32,306 0.99 (0.87, 1.12) 5
CEE 74/7373 0.80 (0.51, 1.24) 22
Southern Europe 248/12,640 0.90 (0.76, 1.08) 0
Northern Europe 268/12,293 1.14 (0.95, 1.35) 0
Additional analysis excluding participants who died within
2 y of follow-up
CVD 11,482/266,860 0.95 (0.86, 1.04) 69
CAD 5501/272,841 0.99 (0.85, 1.14) 62
Stroke 2247/276,095 0.95 (0.89, 1.00) 0
1CAD, coronary artery disease; CHANCES, Consortium on Health and Ageing: Network of Cohorts in Europe and the
United States; CEE, central and eastern Europe; CVD, cardiovascular disease; EPIC-Elderly, European Prospective In-
vestigation into Cancer and Nutrition elderly study; EU, European Union; HAPIEE, Health, Alcohol and Psychosocial
factors in Eastern European countries; SENECA, Survey in Europe on Nutrition and the Elderly; a Concerted Action.
2All models were adjusted for potential confounding variables: sex, education (primary or less, more than primary but
less than college or university, or college or university), alcohol consumption [low (0 g/d), medium (men .0–40 g/d and
women.0–20 g/d), or high (men .40 g/d and women .20 g/d)], smoking status (never, former, or current), energy intake
(kcal/d), and vigorous physical activity (yes or no).
3US = NIH-AARP (16); EU = HAPIEE (all; 15), EPIC-Elderly (all; 14), SENECA (18), and the Rotterdam Study (17);
CEE = HAPIEE (all); southern Europe = EPIC-Elderly (Greece, Spain) and SENECA (south); northern Europe = EPIC-
Elderly (Netherlands, Sweden), the Rotterdam Study, and SENECA (north).
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European countries. Consequently, adherence to the HDI score
was inversely associated with CVD mortality in NIH-AARP.
This points to a specific issue of the HDI, i.e., that it is mostly
based on nutrient recommendations rather than on the con-
sumption of foods. This makes sense, because it was intended to
provide an overall recommendation globally, which could be
locally adapted into food-based dietary guidelines for commu-
nication purposes. A side effect could be that the HDI is not an
optimal indicator of a healthy diet in a specific population, as our
data seem to suggest. On the other hand, our results show that—in
the US and southern European cohorts—a 10-unit increment in
the HDI (corresponding to the IQR) is associated with a re-
duction in CVD mortality of 13% to 15%. This indicates that the
guidelines translated in dietary patterns frequently used in
highly educated US seniors and elderly from southern Europe
are likely to be beneficial from a cardiovascular point of view.
Our findings are based on a meta-analysis of individual par-
ticipant data. Combining cohort studies in a meta-analysis typi-
cally results in a high level of heterogeneity (46). I2 values
decreased considerably after stratification. Regional differences
partly explained the level of heterogeneity, at least for the
southern European countries. The level of heterogeneity within
northern and central eastern Europe remained high and may
have been related to differences in the study design and dietary-
assessment methods used. Moreover, differences in the quality
of health care systems (better medical support and screening
systems) in some cohorts may have influenced the HR estimates
on mortality, which may have resulted in a greater level of
heterogeneity.
Divergent associations across smoking, alcohol use, and ed-
ucation categories showed small levels of heterogeneity due to
large CIs overlapping all point estimates. The differences found
in BMI were mainly driven by SENECA and EPIC-Elderly SE,
which both presented a positive association in the low-BMI group
and an inverse association in the high-BMI group, which could
also be driven by chance findings.
Measurement error of dietary exposure was a major concern in
the current study, as it is in all large cohort studies of diet and
chronic disease. The methods used were validated, but—espe-
cially for the FFQs, which aim to rank subjects according to
intake rather than to estimate absolute intake levels—a calibra-
tion step may be needed when different cohorts are combined
(47). However, we took this problem into account by using
a random-effects meta-analysis, in which subjects with low and
high HDIs were compared within each cohort. Another limita-
tion of our dietary information related to the lack of dietary
intake data during follow-up. The assessments were done only
once, at baseline, which assumed stable dietary patterns over
time. Generally, a single dietary measurement at baseline is
susceptible to misclassification of long-term dietary intake be-
cause of reporting bias and changes occurring in the diet (48,
49). Dietary intake may be quite stable in the elderly (50, 51);
however, because repeated measures over time probably im-
prove estimates of association (52, 53), our result is an un-
derestimation rather than an overestimation of the reported HR
estimate.
Note that one limitation of studying an elderly population may
be the presence of selection bias and missing follow-up data
by “unhealthy” participants. This may have caused an un-
derestimation of the overall pooled results (54, 55). Participants
with prevalent CVD at baseline were excluded to reduce reverse
causation. Our sensitivity analysis, which excluded those par-
ticipants who died within the first 2 y of follow-up, showed
results similar to those of the main analysis, which also made
reverse causation unlikely. Although we excluded prevalent
cases of CVD, we assumed that the result—a healthy diet ac-
cording to WHO guidelines is inversely associated with CVD
mortality—could be extrapolated to the patient group, because
dietary guidelines for CVD prevention and treatment are gen-
erally similar.
Major advantages of this meta-analysis were the use of har-
monized variables and identical analysis scripts across cohorts,
the use of large data sets, the diversity of the population, and
access to the original data. Furthermore, the score construction
was based on the average 85th percentile across cohorts. This
allowed a sufficient level of variation in the HDI score across
cohorts and not only for a specific subcohort on which a cutoff
level could have been assigned. A drawback of most diet scores,
including the HDI score, may be related to missing weighing
factors per recommendation. However, our sensitivity analysis,
which excluded one HDI component at a time, showed com-
parable HR estimates for CVD with different levels of precision,
which indicated that each recommendation is equally important.
Nevertheless, the inclusion of weighing factors may improve the
validity of the HDI. Even though the HDI was shown to decrease
the risk of premature death (9, 11, 12), more research on the
HDI’s content and construct validity and reliability is a logical
step for further analysis (56).
In conclusion, the results of this study show that a healthy diet,
based on the WHO guidelines, is significantly associated with
decreased CVD mortality in US and southern European elderly.
However, nonsignificant associations found for the northern
European countries are possibly attributable to a less healthy
underlying food pattern in comparison with the US and southern
European cohorts. Future studies using the HDI or other nutrient-
based scores should additionally focus on the underlying food
pattern of the studied population.
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